A London based team reimagining the future of behavioural healthcare.
Digital Therapeutics (DigiThera) was founded by a team of medical graduates at Imperial College London. Moved by seeing patients, on a daily basis, suffering with the consequences of avoidable diseases such as smoking, the team recognised the opportunity of early behavioural modification interventions. They set out to build innovative solutions to modern healthcare challenges.
At DigiThera, we believe the real magic of digital health occurs at the intersection of science and design. As such, we utilise a novel management philosophy, combining the agility and instant feedback of a rapid prototyping approach with the rigorous evidence-based approach of medical research to help design innovative new solutions to these challenges. Our aim is to maintain transparency with the scientific community, constantly building on our research. That’s why we pledge to always publish our results in peer-reviewed scientific journals.
We take the view that our unique company culture to be the only sustainable competitive advantage within our control. As such, it has become important for us to define what these core values actually are. This is much more than marketing talk; our core values define our culture, brand and long-term strategies. Learn more about our story here.
Avoidable deaths in the UK
Deaths from avoidable disease in the UK
Cost of avoidable disease in the UK
What is ‘digital therapeutics’?
Digital therapeutics refers to the simple idea that digital behavioural change programmes can be as if not more effective at preventing and treating chronic disease than their pharmaceutical counterparts.
Digital therapeutics is not simply data visualisation. It is about structured behaviour change utilising big data, evidence-based therapies and user-centered design. Like all medical therapies, digital therapeutics must pass the bar of being clinically validated in peer-reviewed publications.
Follow our story, as a small but ambitious digital health startup. We write thought provoking feature length articles covering digital health, gamification, behavioural psychology and the healthcare startup landscape in London.
If you like what we’re doing.
Stay in touch via our very occasional newsletter. We’ll sell our kidneys before we send you any spam!
Smoking is responsible for 100,000 deaths in the UK, with a direct cost of £5.2bn to the NHS. Despite more than 68% of smokers wanting to quit smoking, only 2-3% succeed in the long-term.
Quit Genius utilizes evidence-based principles from gamification combined with cognitive behavioural therapy (CBT) to tackle the developed world’s greatest public health challenge: smoking cessation.
Digital Therapeutics was born when a group of Senior Medical Students and Health Management graduates at Imperial College London came together to tackle an immensely important challenge – how to help the 6.5 million people in the UK, who want to quit smoking, achieve their goals? The journey led them to develop Quit Genius, the world’s first evidence-based game for smoking cessation. The team is focused on using the technology they develop through Quit Genius to eventually tackle other avoidable diseases.
Dr Yusuf Sherwani
Chief Executive Officer
As a doctor, management graduate and serial entrepreneur, Yusuf has been involved in numerous ventures. He founded his first technology business aged 14 which he sold at a profit two years later. He subsequently founded a high-end online audio retailer and a bespoke earphone manufacturer. Yusuf has always been passionate about non-drug behavioural interventions aimed at preventing disease.
Did you know? Aged 14, Yusuf founded and sold a network of online communities to an anonymous Swedish hacker group.
Dr Maroof Ahmed
Chief Operational Officer
Maroof heads up operations at DigiThera. He is passionate about driving the delivery of healthcare through mobile platforms and has worked in the past with 3M health care to develop a mobile application to complement clinical education. In his limited spare time, Maroof is an avid football fan. He enjoys a bit of 5-a-side and the odd United game.
Did you know? Maroof owns over 16 different hair products.
Interim Chief Technology Officer
Tim is responsible for technology at DigiThera. As the previous Chief Technology Officer at Touch Surgery and Marmalade (formerly Ideaworks3D), Tim has deep experience in software product strategy, software development, mobile apps and games. He has hands-on experience building and leading large teams of talented engineers, and passions now include how to unify healthcare, technology and design.
Did you know? Tim has mastered the art of deadpan humour.
Dr Sarim Siddiqui
Chief Medical Officer
Sarim leads the clinical strategy and research team at DigiThera. Sarim has spent three years as an educational lead in Imperial and has directed large international projects towards academic development within Imperial. He has previously spent time doing charitable work and now leads efforts towards evidence-based health behaviour interventions.
Did you know? Sarim has missed more than 10 international flights over the years.
Dr Mo Muntasir
Ex-professional gamer, having once ranked top 8 in Europe for Call of Duty 4, Mo has spent the last few years researching gamification and is spearheading development of the product. With interests in mental health and particularly psychodermatology, he has big ideas for the future of gamified cognitive behavioural therapy.
Did you know? Mo doesn’t use LinkedIn or Twitter.
Dr Sheeraz Iqbal
With experience in both web and mobile application design, Sheeraz heads product design at DigiThera. By combining his skills in ideation with his knowledge of user-centred design, he hopes to fulfil the promise of mobile based healthcare interventions.
Did you know? Sheeraz has broken or fractured 5 different bones – he once somehow broke his arm when going for a run!
Dr Abdu El-Hilly
Chief Strategy Officer
Abdulrahman is responsible for strategy development and execution at Digital Therapeutics. With a varied background including medical education, clinical research and asset management, he applies his wealth of experience to the day-to-day decision making and big picture planning. Abdulrahman is passionate about increasing the availability of quality healthcare and is always looking to test the boundaries of mHealth as a potential solution.
Did you know? Abdu is an Impact Fellow at Singularity University.